JP2022116171A5 - - Google Patents

Download PDF

Info

Publication number
JP2022116171A5
JP2022116171A5 JP2022085223A JP2022085223A JP2022116171A5 JP 2022116171 A5 JP2022116171 A5 JP 2022116171A5 JP 2022085223 A JP2022085223 A JP 2022085223A JP 2022085223 A JP2022085223 A JP 2022085223A JP 2022116171 A5 JP2022116171 A5 JP 2022116171A5
Authority
JP
Japan
Prior art keywords
compound
salt
formula
hydrochloride
ethan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022085223A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022116171A (ja
JP7560511B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2019/051820 external-priority patent/WO2020068530A1/en
Application filed filed Critical
Publication of JP2022116171A publication Critical patent/JP2022116171A/ja
Publication of JP2022116171A5 publication Critical patent/JP2022116171A5/ja
Application granted granted Critical
Publication of JP7560511B2 publication Critical patent/JP7560511B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022085223A 2018-09-26 2022-05-25 6-フルオロ-2-メチルベンゾ[d]チアゾール-5-イル化合物 Active JP7560511B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862736588P 2018-09-26 2018-09-26
US62/736,588 2018-09-26
PCT/US2019/051820 WO2020068530A1 (en) 2018-09-26 2019-09-19 6-fluoro-2-methylbenzo[d]thiazol-5-yl compounds
JP2021516782A JP7081047B2 (ja) 2018-09-26 2019-09-19 6-フルオロ-2-メチルベンゾ[d]チアゾール-5-イル化合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021516782A Division JP7081047B2 (ja) 2018-09-26 2019-09-19 6-フルオロ-2-メチルベンゾ[d]チアゾール-5-イル化合物

Publications (3)

Publication Number Publication Date
JP2022116171A JP2022116171A (ja) 2022-08-09
JP2022116171A5 true JP2022116171A5 (enExample) 2022-09-28
JP7560511B2 JP7560511B2 (ja) 2024-10-02

Family

ID=68085016

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021516782A Active JP7081047B2 (ja) 2018-09-26 2019-09-19 6-フルオロ-2-メチルベンゾ[d]チアゾール-5-イル化合物
JP2022085223A Active JP7560511B2 (ja) 2018-09-26 2022-05-25 6-フルオロ-2-メチルベンゾ[d]チアゾール-5-イル化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021516782A Active JP7081047B2 (ja) 2018-09-26 2019-09-19 6-フルオロ-2-メチルベンゾ[d]チアゾール-5-イル化合物

Country Status (8)

Country Link
US (2) US10752632B2 (enExample)
EP (1) EP3856739A1 (enExample)
JP (2) JP7081047B2 (enExample)
CN (1) CN112955446B (enExample)
AR (1) AR116428A1 (enExample)
CA (1) CA3113968C (enExample)
TW (1) TWI716107B (enExample)
WO (1) WO2020068530A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI716107B (zh) * 2018-09-26 2021-01-11 美商美國禮來大藥廠 6-氟-2-甲基苯并[d]噻唑-5-基化合物
EP4126858A1 (en) * 2020-03-26 2023-02-08 Richter Gedeon Nyrt. Dihydro-2-pyrrolo[3,4-c]pyridine derivatives as gabaa a5 receptor modulators
WO2024081775A1 (en) 2022-10-14 2024-04-18 Eli Lilly And Company Synthesis of 6-fluoro-2-methylbenzo[d]thiazol-5-yl compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8726763D0 (en) 1987-11-16 1987-12-23 Fujisawa Pharmaceutical Co Thiazole compounds
TW504510B (en) * 1996-05-10 2002-10-01 Janssen Pharmaceutica Nv 2,4-diaminopyrimidine derivatives
SE0302116D0 (sv) 2003-07-21 2003-07-21 Astrazeneca Ab Novel compounds
US9120781B2 (en) 2010-05-11 2015-09-01 Simon Fraser University Selective glycosidase inhibitors and uses thereof
CN105143222B (zh) 2013-03-14 2018-02-02 默克专利有限公司 糖苷酶抑制剂
JP6563017B2 (ja) * 2014-08-28 2019-08-21 エースニューロン・ソシエテ・アノニム グリコシダーゼ阻害剤
CN107428762B (zh) 2015-10-30 2020-03-10 四川科伦博泰生物医药股份有限公司 酞嗪酮衍生物、其制备方法及用途
US10913733B2 (en) 2015-12-18 2021-02-09 Alectos Therapeutics Inc. Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses thereof
FR3046053B1 (fr) 2015-12-24 2017-12-22 Sagem Defense Securite Module de pied pour une structure d'exosquelette
CA3012560A1 (en) * 2016-02-25 2017-08-31 Asceneuron S.A. Glycosidase inhibitors
US20200079766A1 (en) * 2016-12-16 2020-03-12 Janssen Pharmaceutica Nv Monocyclic oga inhibitor compounds
US20190359609A1 (en) * 2016-12-16 2019-11-28 Janssen Pharmaceutica Nv Bicyclic oga inhibitor compounds
AR110747A1 (es) 2017-01-27 2019-05-02 Lilly Co Eli Compuestos de 5-metil-1,2,4-oxadiazol-3-ilo
TWI669302B (zh) 2017-05-25 2019-08-21 美商美國禮來大藥廠 5-甲基-1,3,4-<img align="absmiddle" height="18px" width="27px" file="d10999.TIF" alt="其他非圖式 ed10999.png" img-content="tif" orientation="portrait" inline="yes" giffile="ed10999.png"></img>二唑-2-基化合物
TWI716107B (zh) * 2018-09-26 2021-01-11 美商美國禮來大藥廠 6-氟-2-甲基苯并[d]噻唑-5-基化合物

Similar Documents

Publication Publication Date Title
JP2022116171A5 (enExample)
US9242955B2 (en) Synthesis of cyclic carbonates
JP5604424B2 (ja) アポトーシス促進剤abt−263の調製のための方法
JP5513508B2 (ja) アミノスルホン化合物を調製するためのプロセス
US5110987A (en) Method of preparing sphingosine derivatives
HU207057B (en) Process for producing 4-(fluoromethyl)-oxazoline derivatives
JP2023534965A (ja) C-ヌクレオシド化合物の合成方法
JP2019214626A5 (enExample)
JP2014234376A (ja) トリフルオロメタンスルホニル基を含む超原子価ヨウ素イリドを用いるトリフルオロメチルチオ化法
RU2024524C1 (ru) 2,5-диазабицикло [2.2.1] гептановые соединения и способ их получения
JPWO2003064420A1 (ja) 新規光学活性化合物、カルボン酸誘導体の速度論的光学分割方法およびその触媒
CN108373453A (zh) 三氮唑衍生物及其制备方法
JP4948172B2 (ja) 触媒を用いたプロキラル環状無水物およびメソ環状無水物の不斉脱対称化
JP2014009330A5 (enExample)
CN108276350B (zh) 1,2,4-三氮唑及其制备方法
JP2007531704A5 (enExample)
JP4667575B2 (ja) 1,3−ジアルキルイミダゾリウムヨウ素塩の製造方法
JP4474861B2 (ja) 光学活性四級アンモニウム塩、その製造法、並びにそれを用いた光学活性α−アミノ酸誘導体の製造法
JP2011506323A5 (enExample)
JP2006516588A5 (enExample)
JP2014532059A (ja) 新規中間体を介する5−(2−{[6−(2,2−ジフルオロ−2−フェニルエトキシ)ヘキシル]アミノ}−1(r)−ヒドロキシエチル)−8−ヒドロキシキノリン−2(1h)−オンの製造方法
JP2014151285A (ja) 新規光学活性イミダゾリン−リン酸触媒とその誘導体
CN102153470A (zh) 一种制备过酸酯化合物的方法
JPWO2023058781A5 (enExample)
JP2004522793A5 (enExample)